Hints and tips:
...Some observers fear the return of “predictive research”. Alarm was recently sounded in Congress about the risks....
...BioNTech and Pfizer will start a clinical trial of a Covid-19 vaccine adapted to the BA.4 and BA.5 variants of Omicron this month, as the German biotech forecasts an increase in demand at the end of the...
...The bad news came just as Blyth was about to sign a £20mn-plus fundraising round for his Cambridge-based biotech....
...Chinks in the armour As they grapple with these fundamentals, researchers have a new weapon at their disposal: computational predictive modelling....
...AWS sells services from early drug discovery programmes for pharmaceutical companies to predictive analytics for hospitals....
...The only companies that have short positions at a higher percentage of their float are: the biotech company Polarityte; Health Insurance Innovations, which operates a technology platform focused on health...
...We also know that Moderna’s the fifth most-shorted US biotech (with a short interest of 11.76 per cent, or $1.6bn approximately by value), which tends to amplify the price response to whatever news it releases...
...The first company that tried to commercialise a cell therapy, biotech group Dendreon, offers a cautionary tale....
...Last year, Apple acquired UK-based speech technology start-up VocalIQ, and Microsoft paid $250m in February this year for Swiftkey, the London-based predictive keyboard maker....
...That’s what a senior scientist for Biogen, the large US biotech group, told reporters this week....
...She draws on her scientific background to create intellectual property strategies that benefit biotech and pharmaceutical start-ups....
...First, five information economics concepts describe how the paradigm of production, distribution and consumption of products and services are dramatically altered by Big Data and predictive analytics....
...We opened our first Predictive Science Center in Russia in St....
...In medicine, women comprise about 50 per cent of graduates, which is likely to explain the growing number of women entering healthcare and biotech businesses....
...E-therapeutics has worked on projects with GlaxoSmithKline, Mylan Laboratories, Cambridge Laboratories and Chakra Biotech....
...RiskGrades offers an alternative to beta and standard deviation, which Mirsky says is superior to both because it is predictive rather than just describing historical returns....
International Edition